VH Pharma

Beveren-Kruibeke-Zwijndrecht ·KBO/BCE: BE 0788.292.373

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	09-07-2025	22 d early	2025-00255335
31-12-2023	31-07-2024	23-07-2024	8 d early	2024-00278255
31-12-2022	31-07-2023	28-08-2023	28 d late	2023-00358859

Metric	This company	Sector median	Position in the sector
Solvency	20.2%	37.4%	better than 31% of 1407 sector peers
Net result	€155k	€46k	better than 72% of 1406 sector peers
Equity	€198k	€362k	better than 39% of 1407 sector peers
Gross operating margin	€113k	€65k	better than 64% of 1405 sector peers
Employees (FTE)	0.0	0.0	better than 35% of 426 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€979k
Fixed assets	21/28	€866k
Tangible fixed assets	22/27	€352k
Financial fixed assets	28	€514k
Current assets	29/58	€113k
Amounts receivable within one year	40/41	€98k
Cash & bank	54/58	€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€979k
Equity	10/15	€198k
Contributions / capital	10/11	€1k
Reserves	13	€197k
Amounts payable	17/49	€781k
Amounts payable after one year	17	€680k
Amounts payable within one year	42/48	€98k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€113k
Operating result	9901	€101k
Financial income	75	€95k
Financial charges	65	€25k
Result before taxes	9903	€171k
Income taxes	67/77	€16k
Net result for the period	9904	€155k
Result to be appropriated	9905	€155k

Summary